{
  "bundle_id": "PBAC-PEPTIDE-KALLIDIN-KININ-BDKR-ED2-FULL-BUNDLE-001",
  "catalog_id": "PBAC-PEPTIDE-KALLIDIN-KININ-BDKR-ED2-FULL",
  "config_hash_sha256": "d1ac34aae6ec5f168e0c3b7f75f750f83deabbd1a49f7f22a90ec3e6279c6f0b",
  "config_path": "configs/peptide_production/kallidin_kinin_bdkr_ed2_full.json",
  "enablement_packet_id": "PBAC-ENAB-KALLIDIN-KININ-BDKR-EXACT-FORM-V1",
  "enablement_packet_schema_version": "pbac_enablement_packet_v1",
  "enablement_scope": "kallidin_kinin_bdkr_canonical_l_configured_ed2_exact_forms",
  "generated_at_utc": "2026-06-23T11:34:37Z",
  "noncanonical_or_complex_form_requires_specific_packet": true,
  "operational_protocol_excluded": true,
  "reference_ids": [
    "UNIPROT_P01042_KNG1_HUMAN",
    "PUBMED_4307033_MERRIFIELD_SOLID_PHASE_PEPTIDE_SYNTHESIS",
    "PUBMED_2191922_FIELDS_NOBLE_FMOC_SPPS"
  ],
  "release_id": "PBAC-PEPTIDE-KALLIDIN-KININ-BDKR-ED2-FULL-V1",
  "source_reference_catalog_path": "source_reference_catalog.json",
  "synthesis_statement": "Class-specific non-operational enablement context: this packet identifies exact canonical L peptide molecules derived from the curated human lysyl-bradykinin / kallidin peptide parent scaffold and configured terminal, salt, and bridge states. It is not a synthesis protocol, formulation recipe, manufacturing instruction, dosing instruction, assay protocol, safety claim, efficacy claim, target-engagement claim, or therapeutic-use claim."
}
